Margaret Tempero
Internal Medicine · San Francisco, CANPI 1225095730
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $132,537 of the $160,369 with a category attached, or 82.6%. It is spread thinly across 23 manufacturers, the largest accounting for just 18.6%. Among internal medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 82 payments — averaging $1955.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$30K
- E.r. Squibb & Sons, L.L.C.$24K
- AstraZeneca$21K
- Ipsen Biopharmaceuticals, Inc$13K
- Merck$9K
- Astrazeneca UK Limited$8K
- plus $55K from 17 others
Across 13 payments — averaging $46,899 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Roche Products Limited$600K
- Bristol Myers Squibb$8K
- AbbVie$2K
What the payments were for
- Consulting fees$132,53783%
- Speaking & faculty fees$4760%
- Travel & lodging$24,51615%
- Food & beverage$1,1811%
- Education$1,6591%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 9 | $29,818 |
| E.r. Squibb & Sons, L.L.C. | 18 | $24,383 |
| AstraZeneca | 2 | $21,315 |
| Ipsen Biopharmaceuticals, Inc | 6 | $12,770 |
| Merck | 9 | $8,939 |
| Astrazeneca UK Limited | 2 | $8,107 |
| Swedish Orphan Biovitrum AB | 3 | $7,685 |
| Insmed, Inc. | 1 | $5,950 |
| GSK | 1 | $4,800 |
| Janssen Research & Development, LLC | 1 | $4,800 |
| Incyte Corporation | 1 | $4,800 |
| Urogen Pharma, Inc. | 1 | $4,388 |
| Regeneron | 3 | $3,816 |
| Terumo Medical Corporation | 5 | $3,300 |
| Jazz Pharmaceuticals Inc. | 1 | $3,000 |
| Secura Bio, Inc. | 1 | $2,600 |
| Bayer | 1 | $2,457 |
| Seagen Inc. | 2 | $2,354 |
| Bristol Myers Squibb | 10 | $2,177 |
| Beigene USA, Inc. | 1 | $1,800 |
| Mirati Therapeutics, Inc. | 1 | $700 |
| Halozyme Inc | 2 | $336 |
| Pfizer | 1 | $74 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$160,369 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.
Other internal medicine in San Francisco
- Fred CohenSan Francisco$929K
- John TeerlinkSan Francisco$819K
- Mark SmithSan Francisco$535K
- Lisa CapaldiniSan Francisco$434K
- Maria Dall'eraSan Francisco$417K
- Kenneth ColleySan Francisco$397K
- Louis CubbaSan Francisco$351K
- Daniel ButlerSan Francisco$347K
- Laurence CorashSan Francisco$336K
- Felicia StermanSan Francisco$298K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.